# Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer

> **NCT00006459** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** gemcitabine hydrochloride
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00006459
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006459, "Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00006459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*